Who owns Monopar Therapeutics?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MNPR from SEC Form 13F filings across 106 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 106 institutions disclosed 6.2M shares of Monopar Therapeutics worth $495.2M — about 72.6% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
106
13F holders
$495.2M
value, 2026 filers
72.6%
of shares outstanding (6.2M sh)
27
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MNPR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 1.1M | $89.4M | 0.0% | 13.1% | new |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 667,207 | $53.2M | 0.5% | 7.8% | 0.0% |
| 3 | BlackRock, Inc. | 349,244 | $27.8M | 0.0% | 4.1% | +0.1% |
| 4 | Saturn V Capital Management LP | 312,350 | $24.9M | 3.6% | 3.6% | +0.1% |
| 5 | Siren, L.L.C. | 270,118 | $21.5M | 0.5% | 3.2% | 0.0% |
| 6 | STATE STREET CORP | 229,771 | $18.3M | 0.0% | 2.7% | +148.3% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 217,958 | $17.4M | 0.0% | 2.5% | +3.9% |
| 8 | Polar Capital Holdings Plc | 213,811 | $17.0M | 0.0% | 2.5% | -0.3% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 209,195 | $16.7M | 0.0% | 2.4% | 0.0% |
| 10 | TCG Crossover Management, LLC | 202,242 | $16.1M | 0.5% | 2.4% | -0.5% |
| 11 | ADAR1 Capital Management, LLC | 179,032 | $14.3M | 0.6% | 2.1% | -17.7% |
| 12 | Balyasny Asset Management L.P. | 177,180 | $14.1M | 0.0% | 2.1% | +31.7% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 173,645 | $13.8M | 0.0% | 2% | +9.6% |
| 14 | DEERFIELD MANAGEMENT COMPANY, L.P. | 137,591 | $11.0M | 0.2% | 1.6% | -57.5% |
| 15 | Candriam S.C.A. | 129,797 | $10.4M | 0.0% | 1.5% | -9.4% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 119,852 | $9.6M | 0.0% | 1.4% | +6.5% |
| 17 | Alyeska Investment Group, L.P. | 102,228 | $8.1M | 0.0% | 1.2% | +2.2% |
| 18 | Quadrature Capital LtdNEW | 92,499 | $7.4M | 0.0% | 1.1% | new |
| 19 | Vivo Capital, LLC | 90,500 | $7.2M | 0.8% | 1.1% | 0.0% |
| 20 | GOLDMAN SACHS GROUP INC | 87,877 | $7.0M | 0.0% | 1% | +443.8% |
| 21 | Ikarian Capital, LLC | 86,761 | $6.9M | 0.7% | 1% | +81.3% |
| 22 | UBS Group AG | 85,271 | $6.8M | 0.0% | 1% | +212.8% |
| 23 | Driehaus Capital Management LLC | 84,040 | $6.7M | 0.0% | 1% | 0.0% |
| 24 | Bank of New York Mellon Corp | 74,849 | $6.0M | 0.0% | 0.9% | -2.7% |
| 25 | AMERIPRISE FINANCIAL INC | 50,846 | $4.1M | 0.0% | 0.6% | +185.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.